{"id":1126,"date":"2018-04-16T19:55:13","date_gmt":"2018-04-16T19:55:13","guid":{"rendered":"https:\/\/blogs.bmj.com\/jmg\/?p=1126"},"modified":"2026-02-24T15:54:43","modified_gmt":"2026-02-24T15:54:43","slug":"cm-score-a-validated-scoring-system-to-predict-cdkn2a-germline-mutations-in-melanoma-families-from-northern-europe","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/jmg\/2018\/04\/16\/cm-score-a-validated-scoring-system-to-predict-cdkn2a-germline-mutations-in-melanoma-families-from-northern-europe\/","title":{"rendered":"CM-Score: a validated scoring system to predict CDKN2A germline mutations in melanoma families from Northern Europe (Contributed by Dr. Thomas P. Potjer)"},"content":{"rendered":"

The CDKN2A gene is the most important susceptibility gene for skin melanoma. Carriers of a mutation in this gene not only have a high risk to develop one or more melanomas at a young age, but also have an increased risk for other cancers, especially pancreatic cancer and upper airway cancer (mouth and throat). We have developed a scoring system, \u201cCDKN2A Mutation (CM)-Score\u201d, to predict the probability of a CDKN2A mutation in a melanoma family. The scoring system is based on clinical information of melanoma diagnoses in the family, and additionally includes diagnoses of pancreatic and upper airway cancer. Clinical information of 1227 Dutch and 421 Swedish melanoma families was used to create and validate CM-Score. We show that CM-Score is an accurate and reliable prediction tool that is easy to use in clinical practice. (http:\/\/jmg.bmj.com\/content\/early\/2018\/04\/16\/jmedgenet-2017-105205<\/a>)<\/p>\n","protected":false},"excerpt":{"rendered":"

The CDKN2A gene is the most important susceptibility gene for skin melanoma. Carriers of a mutation in this gene not only have a high risk to develop one or more melanomas at a young age, but also have an increased risk for other cancers, especially pancreatic cancer and upper airway cancer (mouth and throat). We […]<\/p>\n

Read More…<\/a><\/p>\n","protected":false},"author":123,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1126","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"\nCM-Score: a validated scoring system to predict CDKN2A germline mutations in melanoma families from Northern Europe (Contributed by Dr. Thomas P. Potjer) - JMG Contact blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/jmg\/2018\/04\/16\/cm-score-a-validated-scoring-system-to-predict-cdkn2a-germline-mutations-in-melanoma-families-from-northern-europe\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CM-Score: a validated scoring system to predict CDKN2A germline mutations in melanoma families from Northern Europe (Contributed by Dr. Thomas P. Potjer) - JMG Contact blog\" \/>\n<meta property=\"og:description\" content=\"The CDKN2A gene is the most important susceptibility gene for skin melanoma. Carriers of a mutation in this gene not only have a high risk to develop one or more melanomas at a young age, but also have an increased risk for other cancers, especially pancreatic cancer and upper airway cancer (mouth and throat). We [...]Read More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/jmg\/2018\/04\/16\/cm-score-a-validated-scoring-system-to-predict-cdkn2a-germline-mutations-in-melanoma-families-from-northern-europe\/\" \/>\n<meta property=\"og:site_name\" content=\"JMG Contact blog\" \/>\n<meta property=\"article:published_time\" content=\"2018-04-16T19:55:13+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-24T15:54:43+00:00\" \/>\n<meta name=\"author\" content=\"hqqu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@HuiQiQu\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"hqqu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2018\\\/04\\\/16\\\/cm-score-a-validated-scoring-system-to-predict-cdkn2a-germline-mutations-in-melanoma-families-from-northern-europe\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2018\\\/04\\\/16\\\/cm-score-a-validated-scoring-system-to-predict-cdkn2a-germline-mutations-in-melanoma-families-from-northern-europe\\\/\"},\"author\":{\"name\":\"hqqu\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\"},\"headline\":\"CM-Score: a validated scoring system to predict CDKN2A germline mutations in melanoma families from Northern Europe (Contributed by Dr. Thomas P. Potjer)\",\"datePublished\":\"2018-04-16T19:55:13+00:00\",\"dateModified\":\"2026-02-24T15:54:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2018\\\/04\\\/16\\\/cm-score-a-validated-scoring-system-to-predict-cdkn2a-germline-mutations-in-melanoma-families-from-northern-europe\\\/\"},\"wordCount\":168,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2018\\\/04\\\/16\\\/cm-score-a-validated-scoring-system-to-predict-cdkn2a-germline-mutations-in-melanoma-families-from-northern-europe\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2018\\\/04\\\/16\\\/cm-score-a-validated-scoring-system-to-predict-cdkn2a-germline-mutations-in-melanoma-families-from-northern-europe\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2018\\\/04\\\/16\\\/cm-score-a-validated-scoring-system-to-predict-cdkn2a-germline-mutations-in-melanoma-families-from-northern-europe\\\/\",\"name\":\"CM-Score: a validated scoring system to predict CDKN2A germline mutations in melanoma families from Northern Europe (Contributed by Dr. Thomas P. Potjer) - JMG Contact blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\"},\"datePublished\":\"2018-04-16T19:55:13+00:00\",\"dateModified\":\"2026-02-24T15:54:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2018\\\/04\\\/16\\\/cm-score-a-validated-scoring-system-to-predict-cdkn2a-germline-mutations-in-melanoma-families-from-northern-europe\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2018\\\/04\\\/16\\\/cm-score-a-validated-scoring-system-to-predict-cdkn2a-germline-mutations-in-melanoma-families-from-northern-europe\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2018\\\/04\\\/16\\\/cm-score-a-validated-scoring-system-to-predict-cdkn2a-germline-mutations-in-melanoma-families-from-northern-europe\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CM-Score: a validated scoring system to predict CDKN2A germline mutations in melanoma families from Northern Europe (Contributed by Dr. Thomas P. Potjer)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"name\":\"JMG Contact blog\",\"description\":\"JMG Contact blog\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\",\"name\":\"JMG Contact blog\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"width\":300,\"height\":34,\"caption\":\"JMG Contact blog\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\",\"name\":\"hqqu\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"caption\":\"hqqu\"},\"description\":\"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.\",\"sameAs\":[\"https:\\\/\\\/x.com\\\/HuiQiQu\"],\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/author\\\/hqiqu\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CM-Score: a validated scoring system to predict CDKN2A germline mutations in melanoma families from Northern Europe (Contributed by Dr. Thomas P. Potjer) - JMG Contact blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/jmg\/2018\/04\/16\/cm-score-a-validated-scoring-system-to-predict-cdkn2a-germline-mutations-in-melanoma-families-from-northern-europe\/","og_locale":"en_US","og_type":"article","og_title":"CM-Score: a validated scoring system to predict CDKN2A germline mutations in melanoma families from Northern Europe (Contributed by Dr. Thomas P. Potjer) - JMG Contact blog","og_description":"The CDKN2A gene is the most important susceptibility gene for skin melanoma. Carriers of a mutation in this gene not only have a high risk to develop one or more melanomas at a young age, but also have an increased risk for other cancers, especially pancreatic cancer and upper airway cancer (mouth and throat). We [...]Read More...","og_url":"https:\/\/blogs.bmj.com\/jmg\/2018\/04\/16\/cm-score-a-validated-scoring-system-to-predict-cdkn2a-germline-mutations-in-melanoma-families-from-northern-europe\/","og_site_name":"JMG Contact blog","article_published_time":"2018-04-16T19:55:13+00:00","article_modified_time":"2026-02-24T15:54:43+00:00","author":"hqqu","twitter_card":"summary_large_image","twitter_creator":"@HuiQiQu","twitter_misc":{"Written by":"hqqu","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/jmg\/2018\/04\/16\/cm-score-a-validated-scoring-system-to-predict-cdkn2a-germline-mutations-in-melanoma-families-from-northern-europe\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2018\/04\/16\/cm-score-a-validated-scoring-system-to-predict-cdkn2a-germline-mutations-in-melanoma-families-from-northern-europe\/"},"author":{"name":"hqqu","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b"},"headline":"CM-Score: a validated scoring system to predict CDKN2A germline mutations in melanoma families from Northern Europe (Contributed by Dr. Thomas P. Potjer)","datePublished":"2018-04-16T19:55:13+00:00","dateModified":"2026-02-24T15:54:43+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2018\/04\/16\/cm-score-a-validated-scoring-system-to-predict-cdkn2a-germline-mutations-in-melanoma-families-from-northern-europe\/"},"wordCount":168,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/jmg\/2018\/04\/16\/cm-score-a-validated-scoring-system-to-predict-cdkn2a-germline-mutations-in-melanoma-families-from-northern-europe\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/jmg\/2018\/04\/16\/cm-score-a-validated-scoring-system-to-predict-cdkn2a-germline-mutations-in-melanoma-families-from-northern-europe\/","url":"https:\/\/blogs.bmj.com\/jmg\/2018\/04\/16\/cm-score-a-validated-scoring-system-to-predict-cdkn2a-germline-mutations-in-melanoma-families-from-northern-europe\/","name":"CM-Score: a validated scoring system to predict CDKN2A germline mutations in melanoma families from Northern Europe (Contributed by Dr. Thomas P. Potjer) - JMG Contact blog","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#website"},"datePublished":"2018-04-16T19:55:13+00:00","dateModified":"2026-02-24T15:54:43+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2018\/04\/16\/cm-score-a-validated-scoring-system-to-predict-cdkn2a-germline-mutations-in-melanoma-families-from-northern-europe\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/jmg\/2018\/04\/16\/cm-score-a-validated-scoring-system-to-predict-cdkn2a-germline-mutations-in-melanoma-families-from-northern-europe\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/jmg\/2018\/04\/16\/cm-score-a-validated-scoring-system-to-predict-cdkn2a-germline-mutations-in-melanoma-families-from-northern-europe\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/jmg\/"},{"@type":"ListItem","position":2,"name":"CM-Score: a validated scoring system to predict CDKN2A germline mutations in melanoma families from Northern Europe (Contributed by Dr. Thomas P. Potjer)"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/jmg\/#website","url":"https:\/\/blogs.bmj.com\/jmg\/","name":"JMG Contact blog","description":"JMG Contact blog","publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/jmg\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/jmg\/#organization","name":"JMG Contact blog","url":"https:\/\/blogs.bmj.com\/jmg\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","contentUrl":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","width":300,"height":34,"caption":"JMG Contact blog"},"image":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b","name":"hqqu","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","caption":"hqqu"},"description":"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.","sameAs":["https:\/\/x.com\/HuiQiQu"],"url":"https:\/\/blogs.bmj.com\/jmg\/author\/hqiqu\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/1126","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/users\/123"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/comments?post=1126"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/1126\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/media?parent=1126"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/categories?post=1126"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/tags?post=1126"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}